Photo: Cosmo Kentish-Barnes
Rebecca says the best-performing stock on the ASX in 2023, has a market cap of about $2.2 billion, it doesn't have an office, and was founded in New Zealand.
She talks about Neuren Pharmaceuticals.
And a2 Milk was put in a trading halt on the New Zealand and Australian stock exchanges on Friday afternoon pending a further announcement about a potential acquisition.
